Alexandra Frogoudaki

Dr. Alexandra Frogoudaki

Adult Congenital Heart Disease Clinic, Second Cardiology Department, ATTIKON University Hospital, National and Kapodistrian University, Athens, Greece

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in EP Europace
Verified
Journal Article
Open access
PDF file
AFAlexandra Frogoudaki
Alexandra Frogoudaki
RSR. Sutton
R. Sutton
MGM. A. Gatzoulis
M. A. Gatzoulis
Aim. Left atrial isomerism (LAI) is an uncommon congenital heart disease, which is combined with a range of intracardiac abnormalities. Atrial arrhythm

Verified
Journal Article
Open access
PDF file
Nikolaos StalikasNikolaos Stalikas
Nikolaos Stalikas
IDIoannis Doundoulakis
Ioannis Doundoulakis
EKEfstratios Karagiannidis
Efstratios Karagiannidis
EBEmmanouil Bouras
Emmanouil Bouras
AKAnastasios Kartas
Anastasios Kartas
George GiannakoulasGeorge Giannakoulas
George Giannakoulas
Adults with congenital heart disease (ACHD) experience more thromboembolic complications than the general population. We systematically searched and critically appraised all studies on the safety and efficacy of non-vitamin-K oral anticoagulants (NOACs) in adult patients with various forms of congenital heart disease. PubMed and the Cochrane Central Register of Controlled Trials (CENTRAL) were used, with duplicate extraction of data and risk of bias assessment. The Newcastle-Ottawa quality assessment scale was used to assess study quality. Three studies fulfilled the inclusion criteria and were analyzed. The total number of participants was 766, with a total follow-up of 923 patient-years. The majority of patients (77%) received a NOAC for atrial arrhythmias, while the remainder were prescribed NOACs for secondary (19%) or primary (4%) thromboprophylaxis. The annual rate of thromboembolic and major bleeding events was low: 0.98% (95% CI: 0.51–1.86) and 1.74% (95% CI: 0.86–3.49) respectively. In Fontan patients, the annual rate of thromboembolic and major bleeding events was 3.13% (95% CI: 1.18–8.03) and 3.17% (95% CI: 0.15–41.39) respectively. NOACs appear safe and effective in ACHD without mechanical prostheses. Additional studies are, however, needed to confirm their efficacy in complex ACHD, especially those with a Fontan-type circulation.

1 November 2020 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
CCChristina Chrysohoou
Christina Chrysohoou
CAConstantina Aggeli
Constantina Aggeli
CACatherine Avgeropoulou
Catherine Avgeropoulou
MAMaria Aroni
Maria Aroni
MBMaria Bonou
Maria Bonou
ASAlexia Stavrati
Alexia Stavrati
The perception that women represent a low risk population for cardiovascular (CV) disease (CVD) needs to be reconsidered. Starting from risk factors, women are more likely to be susceptible to unhealthy behaviors and risk factors that have different impact on CV morbidity and mortality compared to men. Despite the large body of evidence as regards the effect of lifestyle factors on the CVD onset, the gender-specific effect of traditional and non-traditional risk factors on the prognosis of patients with already established CVD has not been well investigated and understood. Furthermore, CVD in women is often misdiagnosed, underestimated and undertreated. Women also experience hormonal changes from adolescence till elder life that affect CV physiology. Unfortunately, in most of the clinical trials women are under-represented, leading to limited knowledge of CV and systemic impact effects of several treatment modalities on women’s health.

14 December 2023 in Open Heart
Verified
Journal Article
Open access
PDF file
CMColin J. McMahon
Colin J. McMahon
IVInga Voges
Inga Voges
PJPetra Jenkins
Petra Jenkins
MBMargarita Brida
Margarita Brida
ABAnnemien E van der Bosch
Annemien E van der Bosch
WBWerner Budts
Werner Budts
Objectives This study aimed to determine the status of training of adult congenital heart disease (ACHD) cardiologists in Europe. Methods A questionnaire was sent to ACHD cardiologists from 34 European countries. Results Representatives from 31 of 34 countries (91%) responded. ACHD cardiology was recognised by the respective ministry of Health in two countries (7%) as a subspecialty. Two countries (7%) have formally recognised ACHD training programmes, 15 (48%) have informal (neither accredited nor certified) training and 14 (45%) have very limited or no programme. Twenty-five countries (81%) described training ACHD doctors ‘on the job’. The median number of ACHD centres per country was 4 (range 0–28), median number of ACHD surgical centres was 3 (0–26) and the median number of ACHD training centres was 2 (range 0–28). An established exit examination in ACHD was conducted in only one country (3%) and formal certification provided by two countries (7%). ACHD cardiologist number versus gross domestic product Pearson correlation coefficient=0.789 (p<0.001). Conclusion Formal or accredited training in ACHD is rare among European countries. Many countries have very limited or no training and resort to ‘train people on the job’. Few countries provide either an exit examination or certification. Efforts to harmonise training and establish standards in exit examination and certification may improve training and consequently promote the alignment of high-quality patient care.

2 January 2020 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
STStavros Tzortzis
Stavros Tzortzis
Ignatios IkonomidisIgnatios Ikonomidis
Ignatios Ikonomidis
HTHELEN TRIANTAFYLLIDI
HELEN TRIANTAFYLLIDI
PTParaskevi Trivilou
Paraskevi Trivilou
George PavlidisGeorge Pavlidis
George Pavlidis
JLJohn Lekakis
John Lekakis

31 March 2008 in Atherosclerosis
Verified
Journal Article
Closed access
PDF file
AFAlexandra Frogoudaki
Alexandra Frogoudaki
JBJohn Barbetseas
John Barbetseas
CAConstadina Aggeli
Constadina Aggeli
DPDemosthenes Panagiotakos
Demosthenes Panagiotakos
SLSpyros Lambrou
Spyros Lambrou
CSChristodoulos Stefanadis
Christodoulos Stefanadis